Orderly process of sequential cytokine stimulation is required for activation and maximal proliferation of primitive human bone marrow CD34+ hematopoietic progenitor cells residing in G0.
[en] Bone marrow (BM) CD34+ cells residing in the G0 phase of cell cycle may be the most suited candidates for the examination of cell cycle activation and proliferation of primitive hematopoietic progenitor cells (HPCs). We designed a double simultaneous labeling technique using both DNA and RNA staining with Hoechst 33342 and Pyronin Y, respectively, to isolate CD34+ cells residing in G0(G0CD34+). Using long-term BM cultures and limiting dilution analysis, G0CD34+ cells were found to be enriched for primitive HPCs. In vitro proliferation of G0CD34+ cells in response to sequential cytokine stimulation was examined in a two-step assay. In the first step, cells received a primary stimulation consisting of either stem cell factor (SCF), Flt3-ligand (FL), interleukin-3 (IL-3), or IL-6 for 7 days. In the second step, cells from each group were washed and split into four or more groups, each of which was cultured again for another week with one of the four primary cytokines individually, or in combination. Tracking of progeny cells was accomplished by staining cells with PKH2 on day 0 and with PKH26 on day 7. Overall examination of proliferation patterns over 2 weeks showed that cells could progress into four phases of proliferation. Phase I contained cytokine nonresponsive cells that failed to proliferate. Phase II contained cells dividing up to three times within the first 7 days. Phases III and IV consisted of cells dividing up to five divisions and greater than six divisions, respectively, by the end of the 14-day period. Regardless of the cytokine used for primary stimulation, G0CD34+ cells moved only to phase II by day 7, whereas a substantial percentage of cells incubated with SCF or FL remained in phase I. Cells cultured in SCF or FL for the entire 14-day period did not progress beyond phase III but proliferated into phase IV (with <20% of cells remaining in phases I and II) if IL-3, but not IL-6, was substituted for either cytokine on day 7. G0CD34+ cells incubated with IL-3 for 14 days proliferated the most and progressed into phase IV; however, when SCF was substituted on day 7, cells failed to proliferate into phase IV. Most intriguing was a group of cells, many of which were CD34+, detected in cultures initially stimulated with IL-3, which remained as a distinct population, mostly in G0/G1, unable to progress out of phase II regardless of the nature of the second stimulus received on day 7. A small percentage of these cells expressed cyclin E, suggesting that their proliferation arrest may have been mediated by a cyclin-related disruption in cell cycle. These results suggest that a programmed response to sequential cytokine stimulation may be part of a control mechanism required for maintenance of proliferation of primitive HPCs and that unscheduled stimulation of CD34+ cells residing in G0 may result in disruption of cell-cycle regulation.
Disciplines :
Hematology
Author, co-author :
Ladd, A. C.
Pyatt, R.
GOTHOT, André ; Centre Hospitalier Universitaire de Liège - CHU > Hématologie biologique et immuno hématologie
Rice, S.
McMahel, J.
Traycoff, C. M.
Srour, E. F.
Language :
English
Title :
Orderly process of sequential cytokine stimulation is required for activation and maximal proliferation of primitive human bone marrow CD34+ hematopoietic progenitor cells residing in G0.
Publication date :
1997
Journal title :
Blood
ISSN :
0006-4971
eISSN :
1528-0020
Publisher :
American Society of Hematology, Washington, United States - District of Columbia
Abramson S, Miller RG, Phillips RA: The identification in adult bone marrow of pluripotent and restricted stem cells of the myeloid and lymphoid systems. J Exp Med 145:1567, 1977
Snodgrass R, Keller G: Clonal fluctuation within the haematopoietic system of mice reconstituted with retrovirus-infected stem cells. EMBO J 6:3955, 1987
Stein GS, Stein JL, van Wijnen AJ, Lian JB, Quesenberry PJ: Molecular mechanisms mediating control of cell cycle and cell growth. Exp Hematol 23:1053, 1995
Ogawa M: Differentiation and proliferation of hematopoietic stem cells. Blood 81:2844, 1993
Srour EF, Leemhuis T, Brandt JE, vanBesien K, Hoffman R: Simultaneous use of rhodamine 123, phycoerythrin, Texas red, and allophycocyanin for the isolation of human hematopoietic progenitor cells. Cytometry 12:179, 1991
Wolf NS, Kone A, Priestley GV, Bartelmez SH: In vivo and in vitro characterization of long-term repopulating primitive hematopoietic cells isolated by sequential Hoechst 33342-rhodamine 123 FACS selection. Exp Hematol 21:614, 1993
Leemhuis T, Yoder MC, Grigsby S, Aguero B, Eder P, Srour E: Isolation of primitive human bone marrow hematopoietic progenitor cells using Hoechst 33342 and Rhodamine 123 Exp Hematol 24:1215, 1996
Darzynkiewicz Z, Traganos F: Multiparameter flow cytometry in studies of the cell cycle, in Melamed MR, Lindmo T, Mendelsohn ML (eds): Flow Cytometry and Sorting (Ed 2). New York, NY, Wiley-Liss, 1990, p 469
Cowden RR, Curtis SK: Supravital experiments with Pyronin Y, a fluorochrome of mitochondria and nucleic acids. Histochemistry 77:535, 1983
Traycoff CM, Abboud MR, Laver J, Brandt JE, Hoffman R, Law P, Ishizawa L, Srour EF: Evaluation of the in vitro behavior of phenotypically defined populations of umbilical cord blood hematopoietic progenitor cells. Exp Hematol 22:215, 1994
Traycoff CM, Kosak ST, Grigsby S, Srour EF: Evaluation of ex vivo expansion potential of cord blood and bone marrow hematopoietic progenitor cells using cell tracking and limiting dilution analysis. Blood 85:2059, 1995
Taswell C: Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J Immunol 126:1614, 1981
Brandt J, Srour EF, vanBesien K, Briddell RA, Hoffman R: Cytokine-dependent long-term culture of highly enriched precursors of hematopoietic progenitor cells from human bone marrow. J Clin Invest 86:932, 1990
Farahat N, van der Plas D, Praxedes M, Morilla R, Matutes E, Catovsky D: Demonstration of cytoplasmic and nuclear antigens in acute leukemia using flow cytometry. J Clin Pathol 47:843, 1994
Gore SD, Amin S, Weng L, Civin CI: Steel factor supports the cycling of isolated human CD34+ cells in the absence of other growth factors. Exp Hematol 23:413, 1995
Neering SJ, Hardy SF, Minamoto D, Kaye Spratt S, Jordan CT: Transduction of primitive human hematopoietic cells with recombinant adenovirus vectors. Blood 88:1147, 1996
Srour E, Bregni M, Traycoff C, Aguero B, Kosak S, Hoffman R, Siena S, Gianni A: Long-term hematopoietic culture-initiating cells are more abundant in mobilized peripheral blood grafts than in bone marrow but have a more limited ex vivo expansion potential. Blood Cells Molecules Dis 22:68, 1996
Srour EF, Brandt JE, Briddell RA, Grigsby S, Leemhuis T, Hoffman R: Long-term generation and expansion of human primitive hematopoietic progenitor cells in vitro. Blood 81:661, 1993
Terstappen LWMM, Huang S, Safford DM, Lansdrop PM, Loken MR: Sequential generations of hematopoietic colonies derived from single nonlineage committed CD34+ CD38- progenitor cells. Blood 77:1218, 1991
Shah AJ, Smogorzewska EM, Hannum C, Crooks GM: Flt3 ligand induces proliferation of quiescent human bone marrow CD34+ CD38-cells and maintains progenitor cells in vitro. Blood 87:3563, 1996
Kobayashi M, Laver JH, Kato T, Miyazaki H, Ogawa M: Thrombopoietin supports proliferation of human primitive hematopoietic cells in synergy with steel factor and/or interleukin-3. Blood 88:429, 1996
Verfaillie C, Blakolmer K, McGlave P: Purified human hematopoietic progenitor cells with long term in vitro repopulating capacity adhere selectively to irradiated bone marrow stroma. J Exp Med 172:509, 1990
Srour EF, Zanjani ED, Cornetta K, Traycoff CM, Flake AW, Hedrick M, Brandt JE, Leemhuis T, Hoffman R: Persistence of human multilineage, self-renewing lymphohematopoietic stem cells in chimeric sheep. Blood 82:3333, 1993
Fleming WH, Alpern EJ, Uchida N, Ikuta K, Spangrude GJ, Weissman IL: Functional heterogeneity is associated with the cell cycle status of murine hematopoietic stem cells. J Cell Biol 122:897, 1993
Goodell MA, Brose K, Paradis G, Stewart Conner A, Mulligan RC: Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 183:1797, 1996
Visser JWM, Bol SJL, van den Engh GJ: Characterization and enrichement of murine hematopoietic stem cells by fluorescence activated cell sorting. Exp Hematol 9:644, 1981
Bertoncello I, Hodgson GS, Bradley TR: Multiparameter analysis of transplantable hematopoietic stem cells. I. The separation and enrichement of stem cells homing to marrow and spleen on the basis of rhodamine 123 fluorescence. Exp Hematol 13:999, 1985
Baum CM, Weissman IL, Tsukamoto AS, Buckle A, Peault B: Isolation of a candidate human hematopoietic stem-cell population. Proc Nat Acad Sci USA 89:2804, 1992
Berardi AC, Wang A, Levine JD, Lopez P, Scadden DT: Functional isolation and characterization of human hematopoietic stem cells. Science 267:104, 1995
Eaves CJ, Cashman JD, Zoumbos NC, Barnett MJ, Eaves AC: Biological strategies for the selective manipulation of normal and leukemic stem cells. Stem Cells 3:109, 1993
Udomsakdi C, Eaves CJ, Sutherland HJ, Lansdorp PM: Separation of functionally distinct subpopulations of primitive human hematopoietic cells using rhodamine-123. Exp Hematol 19:338, 1991
Sutherland HJ, Eaves CJ, Eaves AC, Dragowska W, Lansdorp PM: Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. Blood 74:1563, 1989
Verfaillie CM, Miller JS: A novel single-cell proliferation assay shows that long-term culture-initiating cell (LTC-IC) maintenance over time results from the extensive proliferation of a small fraction of LTC-IC. Blood 86:2137, 1995
Brandt JE, Bhalla K, Hoffman R: Effects of interleukin-3 and c-kit ligand on the survival of various classes of human hematopoietic progenitor cells. Blood 83:1507, 1994
Verfaillie CM: Direct contact between human primitive hematopoietic progenitors and bone marrow stroma is not required for long-term in vitro hematopoiesis. Blood 79:2821, 1992
Tanaka R, Katayama N, Ohishi K, Mahmud N, Itoh R, Tanaka Y, Komada Y, Minami N, Sakurai M, Shirakawa S, Shiku S: Accelerated cell-cycling of hematopoietic progenitor cells by growth factors. Blood 86:73, 1995
Petzer AL, Zandstra PW, Piret JM, Eaves CJ: Differential cytokine effects on primitive (CD34+ CD38-) human hematopoietic cells: Novel responses to Flt-3-ligand and thrombopoietin. J Exp Med 183:2551, 1996
Agrawal YP, Agrawal RS, Sinclair AM, Young D, Maruyama M, Levine F, Ho AD: Cell-cycle kinetics and VSV-G pseudotyped retrovirus-mediated gene transfer in blood-derived CD34+ cells. Exp Hematol 24:738, 1996